Furthermore, two large studies found that abnormal DRE was a stronger predictor of prostate cancer at higher PSA levels [5, 6], indicating that the diagnostic yield of all the patients referred with abnormal DRE (with raised or normal PSA) may have been even higher in our cohort. Here, KLK3 is linked to prostate carcinoma.